Dairy Products With Reduced Sugar and Blood Glucose

Sponsor
Mount Saint Vincent University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04854603
Collaborator
(none)
20
1
5
11.9
1.7

Study Details

Study Description

Brief Summary

Dairy products represent an important food group in human nutrition as a source of calcium, protein, functional fats and low-glycaemic sugar lactose. While traditionally consumed natural milk and yogurt have low sugar content, many flavoured liquid dairy products such as chocolate milk, or fermented products such as yogurt have added sugar. Our recent studies have shown that the partial reduction of added sugar in chocolate milk and yogurt is not associated with any inferior sensory characteristics such as taste and pleasantness compared to their full-sugar counterparts. The current project will investigate whether the liquid dairy products with reduced sugar content (value-added products) have any benefits on blood glucose control in humans.

Condition or Disease Intervention/Treatment Phase
  • Other: Food
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
Treatments will be blinded. The Investigator will be blinded.
Primary Purpose:
Prevention
Official Title:
The Effect of Dairy Products With Reduced Added Sugar Content on Blood Glucose, Satiety and Food Intake
Actual Study Start Date :
Sep 2, 2021
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chocolate milk with a regular added sugar content

Dairy product with a regular sugar content

Other: Food
Dairy products with regular and reduced sugar content and water control.

Experimental: Chocolate milk with a reduced added sugar content

Dairy product with a reduced sugar content

Other: Food
Dairy products with regular and reduced sugar content and water control.

Experimental: Yogurt with a regular added sugar content

Dairy product with a regular sugar content

Other: Food
Dairy products with regular and reduced sugar content and water control.

Experimental: Yogurt with a reduced added sugar content

Dairy product with a reduced sugar content

Other: Food
Dairy products with regular and reduced sugar content and water control.

Experimental: Energy-free control

Potable water

Other: Food
Dairy products with regular and reduced sugar content and water control.

Outcome Measures

Primary Outcome Measures

  1. Blood glucose [0-120 minutes]

    The concentration of blood glucose

  2. Insulin [0-120 minutes]

    The concentration of blood glucose

Secondary Outcome Measures

  1. Satiety [0-120 minutes]

    The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.

  2. Food intake [120 minutes]

    Energy intake with an ad libitum meat at 120 minutes

  3. Thirst [0-120 minutes]

    The subjective perception of thirst measured with 100mm visual analogue scales containing the question "How thirsty do you feel?" and two statements on each pole of 100mm line: "Not thirsty at all" (0mm) and "As thirsty as I have ever felt" (100mm).

  4. Physical comfort [0-120 minutes]

    The subjective feeling of wellness and gastrointestinal discomfort parameters including the feeling of nausea, stomach cramps, flatulency, diarrhea and a subjective feeling of wellness, each measured with 100mm visual analogue scales.

  5. Food pleasantness [at 0 and 120 minutes]

    The perception of pleasantness of the treatments (0 min) and a test meal (at 120 min) will be measured with 100mm visual analogue scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 19-35 y males and females, non-smokers
Exclusion Criteria:
  • having any diseases, irregular menses in females, smoking (all types), taking medications known to influence blood glucose control, skipping breakfast, and having emotional, or learning problems that would affect their ability to participate in the study as required. Individuals with known food allergies and lactose intolerance will be also excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Saint Vincent University Halifax Nova Scotia Canada B3M 2J6

Sponsors and Collaborators

  • Mount Saint Vincent University

Investigators

  • Principal Investigator: Bohdan Luhovyy, PhD, Mount Saint Vincent University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bohdan Luhovyy, Associate Professor, Mount Saint Vincent University
ClinicalTrials.gov Identifier:
NCT04854603
Other Study ID Numbers:
  • 2019-202-01
First Posted:
Apr 22, 2021
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bohdan Luhovyy, Associate Professor, Mount Saint Vincent University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022